FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2528914622> ?p ?o ?g. }

• W2528914622 endingPage "787" @default.
• W2528914622 startingPage "776" @default.
• W2528914622 abstract "BackgroundThere has been tremendous progress regarding treatment options for hepatitis C virus (HCV) infection. Several interferon-free regimens are awaiting regulatory approval. These innovations promise substantial reductions in the burden of disease and side effects as well as a decrease in treatment duration.ObjectivesThe aim of this quantitaitive study was to elicit patient preferences for attributes of innovative antiviral therapies for hepatitis C.MethodsA systematic literature search and 14 semi-structured interviews were performed, resulting in eight patient-relevant characteristics. For the discrete choice experiment, an experimental design (3×3 + 5×6) was generated using Ngene software. The survey was conducted in August 2014 through computer-assisted personal interviews. The data were effects-coded in a random parameter logit estimation.ResultsParticipants were patients with HCV (N = 561; 58.1% men) in different treatment states. The analysis revealed a predominance of the attribute “reaching sustained virological response.” When considering confidence intervals, the results showed three different preference ranks. At first place was “sustained virological response” (level difference [LD] 3.98), second was “anemia” (LD 1.10), followed by “number of interferon injections” (LD 0.92), “rash” (LD 0.82), “nausea and/or diarrhea” (LD 0.79), and “duration of antiviral therapy” (LD 0.78). The last position was occupied by both “tiredness/fatigue” (LD 0.31) and “headache” (LD 0.34).ConclusionsFrom the patients’ point of view, sustained virological response is the most essential criterion for choosing an HCV therapy. It was ranked at the highest, dominating all side effects and modes of administration. Furthermore, this study proved that patients consider both the probability of occurrence and the severity of treatment-induced side effects. Results clearly point to valuation of probabilities that is separate from that of severity." @default.
• W2528914622 created "2016-10-14" @default.
• W2528914622 creator A5054826547 @default.
• W2528914622 creator A5071337587 @default.
• W2528914622 date "2016-09-01" @default.
• W2528914622 modified "2023-09-23" @default.
• W2528914622 title "First and Foremost Battle the Virus: Eliciting Patient Preferences in Antiviral Therapy for Hepatitis C Using a Discrete Choice Experiment" @default.
• W2528914622 cites W1482709825 @default.
• W2528914622 cites W1664760337 @default.
• W2528914622 cites W1964471673 @default.
• W2528914622 cites W1968486838 @default.
• W2528914622 cites W1975498291 @default.
• W2528914622 cites W1980771473 @default.
• W2528914622 cites W1983765304 @default.
• W2528914622 cites W1985996316 @default.
• W2528914622 cites W1990033543 @default.
• W2528914622 cites W1994141249 @default.
• W2528914622 cites W2008929299 @default.
• W2528914622 cites W2027739325 @default.
• W2528914622 cites W2033172119 @default.
• W2528914622 cites W2033442452 @default.
• W2528914622 cites W2035463434 @default.
• W2528914622 cites W2040313649 @default.
• W2528914622 cites W2043193067 @default.
• W2528914622 cites W2046376969 @default.
• W2528914622 cites W2056239383 @default.
• W2528914622 cites W2064546869 @default.
• W2528914622 cites W2066524305 @default.
• W2528914622 cites W2073832435 @default.
• W2528914622 cites W2079315402 @default.
• W2528914622 cites W2080983682 @default.
• W2528914622 cites W2094422835 @default.
• W2528914622 cites W2107512529 @default.
• W2528914622 cites W2114163247 @default.
• W2528914622 cites W2117115804 @default.
• W2528914622 cites W2121722424 @default.
• W2528914622 cites W2122707212 @default.
• W2528914622 cites W2124403788 @default.
• W2528914622 cites W2125963799 @default.
• W2528914622 cites W2128100529 @default.
• W2528914622 cites W2132320742 @default.
• W2528914622 cites W2138363476 @default.
• W2528914622 cites W2141214317 @default.
• W2528914622 cites W2143468834 @default.
• W2528914622 cites W2143559032 @default.
• W2528914622 cites W2146430681 @default.
• W2528914622 cites W2154658415 @default.
• W2528914622 cites W2157129193 @default.
• W2528914622 cites W2159936838 @default.
• W2528914622 cites W2162712320 @default.
• W2528914622 cites W2166118716 @default.
• W2528914622 cites W2222306685 @default.
• W2528914622 cites W2273045566 @default.
• W2528914622 cites W2326572641 @default.
• W2528914622 cites W24970867 @default.
• W2528914622 cites W3124228313 @default.
• W2528914622 cites W4210284068 @default.
• W2528914622 cites W4241616429 @default.
• W2528914622 cites W4368066315 @default.
• W2528914622 doi "https://doi.org/10.1016/j.jval.2016.04.007" @default.
• W2528914622 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27712705" @default.
• W2528914622 hasPublicationYear "2016" @default.
• W2528914622 type Work @default.
• W2528914622 sameAs 2528914622 @default.
• W2528914622 citedByCount "15" @default.
• W2528914622 countsByYear W25289146222016 @default.
• W2528914622 countsByYear W25289146222017 @default.
• W2528914622 countsByYear W25289146222018 @default.
• W2528914622 countsByYear W25289146222019 @default.
• W2528914622 countsByYear W25289146222020 @default.
• W2528914622 countsByYear W25289146222021 @default.
• W2528914622 crossrefType "journal-article" @default.
• W2528914622 hasAuthorship W2528914622A5054826547 @default.
• W2528914622 hasAuthorship W2528914622A5071337587 @default.
• W2528914622 hasBestOaLocation W25289146221 @default.
• W2528914622 hasConcept C126322002 @default.
• W2528914622 hasConcept C151956035 @default.
• W2528914622 hasConcept C203014093 @default.
• W2528914622 hasConcept C2522874641 @default.
• W2528914622 hasConcept C2776408679 @default.
• W2528914622 hasConcept C2776455275 @default.
• W2528914622 hasConcept C2778570526 @default.
• W2528914622 hasConcept C2779802037 @default.
• W2528914622 hasConcept C2780580376 @default.
• W2528914622 hasConcept C44249647 @default.
• W2528914622 hasConcept C71924100 @default.
• W2528914622 hasConceptScore W2528914622C126322002 @default.
• W2528914622 hasConceptScore W2528914622C151956035 @default.
• W2528914622 hasConceptScore W2528914622C203014093 @default.
• W2528914622 hasConceptScore W2528914622C2522874641 @default.
• W2528914622 hasConceptScore W2528914622C2776408679 @default.
• W2528914622 hasConceptScore W2528914622C2776455275 @default.
• W2528914622 hasConceptScore W2528914622C2778570526 @default.
• W2528914622 hasConceptScore W2528914622C2779802037 @default.
• W2528914622 hasConceptScore W2528914622C2780580376 @default.
• W2528914622 hasConceptScore W2528914622C44249647 @default.
• W2528914622 hasConceptScore W2528914622C71924100 @default.
• W2528914622 hasIssue "6" @default.

• next